Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010–2019)
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is associated with anincreased risk of obesity, compensatory hyperinsulinemia, dyslipidemia, metabolic syndrome, and endometrial cancer. Thisstudy analyzed 544619 women using the Korean Informative Classification of Disease, version 10, codes E28.0–E28.9 in the popu lation-based National Health Information Databases from 2010 to 2019. The age-adjusted incidence and prevalence rates of PCOSover 10 years among Korean women were 2.8% and 4.3%, respectively; and they increased in the late teens, peaked in the 20s, andbegan to decrease at the age of 30. We also found that the body mass index, levels of fasting blood glucose, and high-density lipo protein values in the recent two years (2018–2019) were higher in women with PCOS compared to the general population. This is thefirst study to investigate the prevalence of PCOS in a nationwide population of reproductive-aged Korean women. Further researchis needed to examine the short- and long-term health risks and psychological problems associated with PCOS.
Abstract
Polycystic ovarian syndrome (PCOS) is a common endocrine disorder in women of reproductive age and is associated with anincreased risk of obesity, compensatory hyperinsulinemia, dyslipidemia, metabolic syndrome, and endometrial cancer. Thisstudy analyzed 544619 women using the Korean Informative Classification of Disease, version 10, codes E28.0–E28.9 in the popu lation-based National Health Information Databases from 2010 to 2019. The age-adjusted incidence and prevalence rates of PCOSover 10 years among Korean women were 2.8% and 4.3%, respectively; and they increased in the late teens, peaked in the 20s, andbegan to decrease at the age of 30. We also found that the body mass index, levels of fasting blood glucose, and high-density lipo protein values in the recent two years (2018–2019) were higher in women with PCOS compared to the general population. This is thefirst study to investigate the prevalence of PCOS in a nationwide population of reproductive-aged Korean women. Further researchis needed to examine the short- and long-term health risks and psychological problems associated with PCOS.
참고문헌 (33)
- Gülay Çiftci, "Update on polycystic ovary syndrome", Clinical and Experimental Reproductive Medicine, 48(3), pp.194~197 (2021), 대한생식의학회[DOI]
- Shermin S, "Polycystic ovary syndrome : a brief review with recent updates", Delta Med Coll J, 7, pp.84~99 (2019)
- Teede HJ, "Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome", Hum Reprod, 33, pp.1602~1618 (2018)
- Barry JA, "Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome : a systematic review and meta-analysis", Hum Reprod Update, 20, pp.748~758 (2014)
- Gilbert EW, "Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews", Clin Endocrinol (Oxf), 89, pp.683~699 (2018)
- Hart R, "The potential implications of a PCOS diagnosis on a woman’s long-term health using data linkage", J Clin Endocrinol Metab, 100, pp.911~919 (2015)
- Jalilian A, "Prevalence of polycystic ovary syndrome and its associated complications in Iranian women : a meta-analysis", Iran J Reprod Med, 13, pp.591~604 (2015)
- Li R, "Prevalence of polycystic ovary syndrome in women in China : a large community-based study", Hum Reprod, 28, pp.2562~2569 (2013)
- Otaghi M, "The association between metabolic syndrome and polycystic ovary syndrome : a systematic review and meta-analysis", Diabetes Metab Syndr, 13, pp.1481~1489 (2019)
- Deswal R, "The prevalence of polycystic ovary syndrome : a brief systematic review", J Hum Reprod Sci, 13, pp.261~271 (2020)
- Ding T, "The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity : a systematic review and meta-analysis", Oncotarget, 8, pp.96351~96358 (2017)
- March WA, "The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria", Hum Reprod, 25, pp.544~551 (2010)
- Landis SH, "Continuing to Confront COPD International Patient Survey : methods, COPD prevalence, and disease burden in 2012-2013", Int J Chron Obstruct Pulmon Dis, 9, pp.597~611 (2014)
- Lee J, "Cohort profile : the National Health Insurance Service-National Sample Cohort(NHIS-NSC), South Korea", Int J Epidemiol, 46, pp.e15~ (2017)
- Gordis L, "Epidemiology" (2009), Saunders
- Hu S, "The accumulation of the glycoxidation product N(ε)-carboxymethyllysine in cardiac tissues with age, diabetes mellitus and coronary heart disease", Tohoku J Exp Med, 230, pp.25~32 (2013)
- Weir CJ, "Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study", BMJ, 314, pp.1303~1306 (1997)
- Avisar I, "The prevalence of polycystic ovary syndrome in women with idiopathic intracranial hypertension", Scientifica(Cairo), 2012, pp.708042~ (2012)
- Park YJ, "Menstrual cycle patterns and the prevalence of premenstrual syndrome and polycystic ovary syndrome in Korean young adult women", Healthcare(Basel), 9, pp.56~ (2021)
- 변은경, "서울지역 여자대학생에서 다낭성난소증후군의 유병률", Endocrinology and Metabolism, 20(2), pp.120~126 (2005), 대한내분비학회
- Liu J, "Measuring the global disease burden of polycystic ovary syndrome in 194 countries : Global Burden of Disease Study 2017", Hum Reprod, 36, pp.1108~1119 (2021)
- Ganie MA, "Prevalence of polycystic ovary syndrome(PCOS)among reproductive age women from Kashmir valley : a cross-sectional study", Int J Gynaecol Obstet, 149, pp.231~236 (2020)
- Witchel SF, "Polycystic ovary syndrome : pathophysiology, presentation, and treatment with emphasis on adolescent girls", J Endocr Soc, 3, pp.1545~1573 (2019)
- Qureshi SS, "Prevalence and risk factor of polycystic ovarian syndrome", Asian J Pharm Clin Res, 9, pp.23~25 (2016)
- Choi YM, "Progression to prediabetes or diabetes in young Korean women with polycystic ovary syndrome: a longitudinal observational study", Clin Endocrinol (Oxf), 94, pp.837~844 (2021)
- Escobar-Morreale HF, "Circulating inflammatory markers in polycystic ovary syndrome : a systematic review and metaanalysis", Fertil Steril, 95, pp.1048~1058.e1-2 (2011)
- Kakoly NS, "Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS : a systematic review and meta-regression", Hum Reprod Update, 24, pp.455~467 (2018)
- Kim JJ, "Phenotype and genotype of polycystic ovary syndrome in Asia : ethnic differences", J Obstet Gynaecol Res, 45, pp.2330~2337 (2019)
- Kyrkou G, "Metabolic syndrome in Greek women with polycystic ovary syndrome : prevalence, characteristics and associations with body mass index. A prospective controlled study", Arch Gynecol Obstet, 293, pp.915~923 (2016)
- Lizneva D, "Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations : systematic review and meta-analysis", Fertil Steril, 106, pp.1510~1520.e2 (2016)
- Lo JC, "Risk of type 2 diabetes mellitus following gestational diabetes pregnancy in women with polycystic ovary syndrome", J Diabetes Res, 2017, pp.5250162~ (2017)
- Mills G, "Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy : a population-based study on 9. 1 million pregnancies", Hum Reprod, 35, pp.1666~1674 (2020)
- Carmina E, "Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily", Clin Endocrinol(Oxf), 91, pp.553~560 (2019)